Company performance
Add to research
Current Price
as of Jun 18, 2025$124.00
P/E Ratio
91.14
Market Cap
$4.2B
Description
Add to research
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Metrics
Add to research
Overview
- HQAndover, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerTMDX
- Price$124-8.96%
Trading Information
- Market cap$4.20B
- Float96.29%
- Average Daily Volume (1m)823,643
- Average Daily Volume (3m)1,061,797
- EPS$1.46
Company
- Revenue$488.23M
- Rev growth (1yr)48.21%
- Net income$25.68M
- Gross margin61.40%
- EBITDA margin23.39%
- EBITDA$33.58M
- EV$2.89B
- EV/Revenue5.93
- P/E91.14
- P/S10.14
- P/B15.75
- Debt/Equity194.67
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account